Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sobayovivo
- Development stage
- Unknown
- Lead developer
- Bakhtar Bioshimi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sobayovivo is an oral small molecule medication developed and manufactured by the Iranian pharmaceutical company Bakhtar Bioshimi for the treatment of chronic Hepatitis C. The drug's active ingredient is sofosbuvir, a nucleotide analog inhibitor that targets the Hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase. As a prodrug, it is intracellularly metabolized to its active triphosphate form, which acts as a chain terminator during viral RNA replication, thereby inhibiting the replication of the virus. Sobayovivo is marketed in Iran, specifically in a 400 mg dosage form, and is part of Bakhtar Bioshimi's extensive portfolio of antiviral and CNS medications.
- Brand names
- SobayovivoSobayovivo 400Sobayovivo400Sobayovivo-400
- Other names
- sofosbuvirسوبایوویو ۴۰۰
02
Targets
NS5B (Hepatitis C virus non-structural protein 5B (NS5B) RNA-dependent RNA polymerase)
Beyond the preview
Go deeper on Sobayovivo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sobayovivo.